These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 6148792)

  • 1. [Complications of drug withdrawal from antiparkinson agents and neuroleptics].
    Mizon JP; Rosa A
    Therapie; 1984; 39(4):421-5. PubMed ID: 6148792
    [No Abstract]   [Full Text] [Related]  

  • 2. [Withdrawal symptoms of neuroleptics?].
    Mager T
    Med Monatsschr Pharm; 1994 Aug; 17(8):252. PubMed ID: 7935155
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic-induced supersensitivity psychosis, the "hump course," and tardive dyskinesia.
    Chovinard G; Jones B
    J Clin Psychopharmacol; 1982 Apr; 2(2):143-4. PubMed ID: 6122695
    [No Abstract]   [Full Text] [Related]  

  • 4. Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug-induced psychosis.
    Arnold G; Trenkwalder C; Schwarz J; Oertel WH
    Mov Disord; 1994 Mar; 9(2):238-40. PubMed ID: 7910949
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiparkinsonics, neuroleptics, and tardive dyskinesia.
    Mallya A; Jose C; Baig M; Williams R; Cho D; Mehta D; Volavka J
    Biol Psychiatry; 1979 Aug; 14(4):645-9. PubMed ID: 39640
    [No Abstract]   [Full Text] [Related]  

  • 6. What to do when Sinemet fails: Part one.
    Klawans HL
    Clin Neuropharmacol; 1984; 7(2):121-33. PubMed ID: 6733692
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term neurologic complications of metoclopramide.
    Patel M; Louis S
    N Y State J Med; 1986 Apr; 86(4):210. PubMed ID: 3459076
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiparkinson drugs in neuroleptic treatment: comparative study of progressive and abrupt withdrawal].
    Ben Hadj Ali B; Dogui M; Ben Ammou S; Lôo H
    Encephale; 1995; 21(3):209-15. PubMed ID: 7649071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible withdrawal dyskinesia associated with quetiapine.
    Michaelides C; Thakore-James M; Durso R
    Mov Disord; 2005 Jun; 20(6):769-70. PubMed ID: 15747370
    [No Abstract]   [Full Text] [Related]  

  • 10. [Late extrapyramidal hyperkinesis and neuroleptic withdrawal dyskinesia. Practical problems].
    Hoffmann C; Faust V
    Fortschr Med; 1983 Mar; 101(11):470-6. PubMed ID: 6133824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes.
    Chouinard G; Chouinard VA
    Psychother Psychosom; 2008; 77(2):69-77. PubMed ID: 18230939
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients.
    Grimes JD
    Can Med Assoc J; 1982 Mar; 126(5):468. PubMed ID: 6121618
    [No Abstract]   [Full Text] [Related]  

  • 13. Propranolol for tardive dyskinesia and extrapyramidal side effects (pseudoparkinsonism) from neuroleptics.
    Kulik FA; Wilbur R
    Psychopharmacol Bull; 1980 Jul; 16(3):18-9. PubMed ID: 6105690
    [No Abstract]   [Full Text] [Related]  

  • 14. [Parkinson syndrome: iatrogenic causes, iatrogenic treatment results].
    Burgunder JM
    Schweiz Med Wochenschr; 1996 Mar; 126(13):522-7. PubMed ID: 8658091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
    Chouinard G; Bradwejn J; Annable L; Jones BD; Ross-Chouinard A
    J Clin Psychiatry; 1984 Dec; 45(12):500-2. PubMed ID: 6150030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes.
    Rich SS; Friedman JH; Ott BR
    J Clin Psychiatry; 1995 Dec; 56(12):556-9. PubMed ID: 8530331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone-induced tardive dyskinesia and parkinsonism.
    Gwinn KA; Caviness JN
    Mov Disord; 1997 Jan; 12(1):119-21. PubMed ID: 8990067
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic-induced reinnervation sprouting in the central nervous system (a model for the development of tardive dyskinesia and supersensitivity psychosis).
    Staton RD; Brumback RA
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 1):427-8. PubMed ID: 6108320
    [No Abstract]   [Full Text] [Related]  

  • 19. Zotepine in levodopa-induced Psychosis.
    Spieker S; Stetter F; Klockgether T
    Mov Disord; 1995 Nov; 10(6):795-7. PubMed ID: 8750001
    [No Abstract]   [Full Text] [Related]  

  • 20. [Are the antipsychotic and side-effects of neuroleptics imperfectly known?].
    Schulz P
    Biomed Pharmacother; 1987; 41(1):31-3. PubMed ID: 2886159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.